Cargando…
Effectiveness of bosentan in the treatment of systemic sclerosis-related digital ulcers: Systematic review and meta-analysis
BACKGROUND: The aim of the present systematic review and meta-analysis was to evaluate the therapeutic efficacy of bosentan, a dual endothelin receptor antagonist, for systemic sclerosis (SSc) patients with digital ulcers (DUs). MATERIALS AND METHODS: A systematic search of MEDLINE, Embase, Web of S...
Autores principales: | Hosseinbalam, Marziyeh, Nouri, Rasool, Farajzadegan, Ziba, Mottaghi, Peyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039099/ https://www.ncbi.nlm.nih.gov/pubmed/36974107 http://dx.doi.org/10.4103/jrms.jrms_386_22 |
Ejemplares similares
-
Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers
por: Castellví, Ivan, et al.
Publicado: (2020) -
Digital ulcers secondary to Sneddon’s syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis
por: Barnini, Tommaso, et al.
Publicado: (2012) -
Intrauterine device survival in Iranian women: systematic review and meta-analysis
por: Farajzadegan, Ziba, et al.
Publicado: (2015) -
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
por: Matucci-Cerinic, Marco, et al.
Publicado: (2010) -
Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)